Lyfegen Revenue and Competitors

Basel,

Location

#5193

Growjo Ranking

Estimated Revenue & Valuation

  • Lyfegen's estimated annual revenue is currently $3.9M per year.(i)
  • Lyfegen's estimated revenue per employee is $116,000

Employee Data

  • Lyfegen has 34 Employees.(i)
  • Lyfegen grew their employee count by 31% last year.

Lyfegen's People

NameTitleEmail/Phone
1
CEO, FounderReveal Email/Phone
2
CFO, Co-FounderReveal Email/Phone
3
Global VP Sales and Business DevelopmentReveal Email/Phone
4
CEO & FounderReveal Email/Phone
5
VP Sales and Business DevelopmentReveal Email/Phone
6
VP Sales & Business DevelopmentReveal Email/Phone
7
VP Sales and Business DevelopmentReveal Email/Phone
8
Head TechnologyReveal Email/Phone
9
Chief Customer Experience Officer & FounderReveal Email/Phone
10
Global MarketingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$57.6M31824%N/AN/A
#2
$44.6M28623%$25.4MN/A
#3
$5.1M44-6%N/AN/A
#4
$35.1M225-3%$46.9MN/A
#5
$14.5M1005%N/AN/A
#6
$1.3M15-6%N/AN/A
#7
$1.5M170%N/AN/A
#8
$2.9M29-12%N/AN/A
#9
$125.2M6916%N/AN/A
#10
$95.9M529-1%N/AN/A
Add Company

What Is Lyfegen?

Lyfegen helps patients to access cutting edge, high-cost therapies with our groundbreaking value-based contracting platform. Our solutions provide manufacturers, healthcare payers, and healthcare providers the tools needed to execute value-based and data-driven agreements. Our Solutions Lyfevalue: Bringing manufacturers and healthcare payers together in outcome-based contracting as no platform has ever before. Lyfeapp: Giving healthcare professionals an innovative patient management solution to collect and analyze patient data securely. Discover more and book a demo on our website lyfegen.com

keywords:N/A

N/A

Total Funding

34

Number of Employees

$3.9M

Revenue (est)

31%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.3M3417%N/A
#2
$5.4M359%N/A
#3
$7.3M366%N/A
#4
$7M40-30%N/A
#5
N/A438%N/A